FMC

FMC Corporation Q1 2005 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2005. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The company reported strong first-quarter performance across all businesses, driven by price increases in Industrial Chemicals and increased sales volumes in Agricultural Products.

Key Financial Metrics

Note: Operating cash flow was negative due to working capital changes, but improved significantly compared to the prior year. Discontinued operations provided $48.6 million in cash flow, primarily from asset sales.

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenue increased 9% to $552.4 million, driven by a 14% increase in Agricultural Products and a 10% increase in Industrial Chemicals.
• Profitability Surge: Net income jumped from $5.5 million to $64.5 million. This was largely due to a $29.0 million gain from discontinued operations (sale of San Jose real estate) and improved operating margins in continuing operations.
• Segment Performance:
  • Agricultural Products: Operating profit rose 71% to $33.6 million due to higher insecticide sales in Brazil.
  • Industrial Chemicals: Operating profit tripled to $21.6 million, driven by significant price increases in soda ash.
  • Specialty Chemicals: Operating profit increased 15% to $28.4 million.
• Discontinued Operations: The company recorded a $29.0 million net gain, primarily from the $56.1 million proceeds from the sale of 52 acres of former Defense Systems land in San Jose, California.
• Restructuring: Charges totaled $3.3 million in Q1 2005 (vs. $1.3 million in Q1 2004), including severance and asset abandonment charges.

Guidance, Outlook, and Risks

• 2005 Outlook:
  • Agricultural Products: Expect modest revenue growth and ~10% earnings growth.
  • Specialty Chemicals: Expect mid-single digit revenue growth with earnings growth exceeding sales growth.
  • Industrial Chemicals: Expect mid-to-high single digit revenue growth and ~60% earnings growth driven by higher selling prices.
• Liquidity: The company expects debt balances net of cash to be approximately $220 million lower than year-end 2004. Revolving credit availability stands at $353.1 million.
• Future Charges: Management announced the closure of carrageenan plants in Copenhagen and Bezons, expecting a pre-tax charge of approximately $30 million in Q2 and Q3 2005. An additional $3.0 million charge is expected in Q2 2005 for accelerated depreciation in Agricultural Products.
• Legal and Regulatory Risks:
  • Antitrust: Subject to investigations by the European Commission and a U.S. grand jury regarding hydrogen peroxide competition (1994-2003). Class action lawsuits have been filed.
  • Environmental: Projected remediation spending for 2005 is approximately $54.0 million. Potential contingent losses may exceed accrued amounts by up to $75 million.
  • Joint Venture: Ongoing litigation with Solutia (partner in Astaris joint venture) regarding technology contributions, though some claims were recently dismissed.

Investor Verification Checklist

• Verify the sustainability of the $29.0 million gain from discontinued operations (one-time real estate sale) when assessing core earnings power.
• Monitor the impact of the announced $30 million restructuring charge for plant closures in Q2/Q3 2005.
• Review the status of antitrust investigations in the hydrogen peroxide market and potential fines or settlements.
• Assess the financial health of the Astaris joint venture and the impact of Solutia's Chapter 11 bankruptcy proceedings on FMC's investment.
• Confirm the realization of projected price increases in the Industrial Chemicals segment (soda ash) to meet the 60% earnings growth target.